Gain Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DME CAPITAL MANAGEMENT, LP | 05/15/2025 | 566.13 K | $1.08 M | 0.00% | 1.97% |
JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 427.70 K | $808.35 K | 335.32% | 1.49% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 282.21 K | $539.09 K | 5.53% | 0.98% |
VANGUARD GROUP INC | 05/09/2025 | 254.99 K | $487.03 K | 44.00% | 0.89% |
MARSHALL WACE, LLP | 05/15/2025 | 196.03 K | $374.41 K | 113.68% | 0.68% |
GOTHAM ASSET MANAGEMENT, LLC | 05/15/2025 | 153.98 K | $3.17 M | -2.64% | 0.54% |
05/07/2025 | 125.58 K | $239.87 K | 100.00% | 0.44% | |
NORTHERN TRUST CORP | 05/13/2025 | 100.17 K | $191.33 K | 18.42% | 0.35% |
MORGAN STANLEY | 05/15/2025 | 99.80 K | $190.61 K | 12.75% | 0.35% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 85.96 K | $164.18 K | 83.23% | 0.30% |
BLACKROCK, INC. | 05/02/2025 | 84.41 K | $161.22 K | -1.92% | 0.29% |
STATE STREET CORP | 05/15/2025 | 71.14 K | $135.87 K | 0.00% | 0.25% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 59.50 K | $114.00 K | 9.17% | 0.21% |
KOVITZ INVESTMENT GROUP PARTNERS, LLC | 05/19/2025 | 47.58 K | $90.87 K | 100.00% | 0.17% |
UBS GROUP AG | 05/13/2025 | 43.36 K | $82.82 K | 23.09% | 0.15% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 35.82 K | $68.42 K | 0.00% | 0.12% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 30.00 K | $57.31 K | 0.00% | 0.10% |
QUADRATURE CAPITAL LTD | 05/13/2025 | 20.15 K | $38.29 K | 100.00% | 0.07% |
CITADEL ADVISORS LLC | 05/15/2025 | 19.02 K | $36.33 K | 63.79% | 0.07% |
BENEDICT FINANCIAL ADVISORS INC | 05/07/2025 | 18.00 K | $34.38 K | 12.50% | 0.06% |
SANDHILL CAPITAL PARTNERS LLC | 05/14/2025 | 15.40 K | $29.41 K | 0.00% | 0.05% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 14.36 K | $27.42 K | 100.00% | 0.05% |
SPROTT INC. | 05/14/2025 | 14.00 K | $26.74 K | 0.00% | 0.05% |
05/08/2025 | 10.75 K | $22.04 K | 100.00% | 0.04% | |
NEWEDGE ADVISORS, LLC | 05/15/2025 | 10.60 K | $20.25 K | 100.00% | 0.04% |
CITADEL ADVISORS LLC | 05/15/2025 | 8.70 K | $16.62 K | -17.92% | 0.03% |
CITADEL ADVISORS LLC | 05/15/2025 | 8.40 K | $16.04 K | 47.37% | 0.03% |
CREEKMUR ASSET MANAGEMENT LLC | 05/05/2025 | 4.44 K | $8.48 K | 0.00% | 0.02% |
MAI CAPITAL MANAGEMENT | 05/15/2025 | 4.41 K | $8.42 K | 0.00% | 0.02% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 4.10 K | $7.84 K | 0.42% | 0.01% |
SIMPLEX TRADING, LLC | 05/12/2025 | 3.44 K | $6.00 K | 100.00% | 0.01% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 2.65 K | $5.06 K | 0.00% | 0.01% |
SRS CAPITAL ADVISORS, INC. | 05/15/2025 | 2.50 K | $4.78 K | 100.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.43 K | $4.65 K | 100.00% | 0.01% |
FMR LLC | 05/12/2025 | 80 | $154 | 100.00% | 0.00% |
CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Gain Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Gain Therapeutics, Inc.. The most heavily invested institutionals were:
DME Capital Management, LP: 566,130
JONES FINANCIAL COMPANIES LLLP: 427,700
GEODE CAPITAL MANAGEMENT, LLC: 282,211
VANGUARD GROUP INC: 254,990
MARSHALL WACE, LLP: 196,026
Gotham Asset Management, LLC: 153,984
9.80% of Gain Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.47 M shares in the last 24 months. This purchase volume represents approximately $5.83 M in transactions.